WCN26-4848 A Case of Lysozyme-Induced Nephropathy Improved by Treatment for Chronic Myelomonocytic Leukemia

Read full text Summarise with VIRAT
Authors: Daichi Fukaya, Hisashi Furukawa, Minako Tanioka, Hiroaki Amano, Koji Tomori, Yusuke Watanabe, Tsutomu Inoue, Hirokazu Okada
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

【Introduction】 Lysozyme is a low molecular weight protein of 15 kilodaltons produced by monocytes and macrophages. It is freely filtered by the glomerulus and reabsorbed in the proximal tubule. In monocytic leukemias such as chronic myelomonocytic leukemia (CMML), excessive lysozyme production may occur. This excess lysozyme deposits in the proximal tubules, causing a rare acute kidney injury termed lysozyme-induced nephropathy (LyN).

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Acute Kidney Injury Research Multiple Myeloma Research and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
103976–103976
Publication date
25 March 2026
Language
EN